Landovitz RJ, Pinedo Y, Hinestrosa F, Crofoot GE, et al. Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study. Clin Infect Dis 2026 Mar 14:ciag171. doi: 10.1093.
PMID: 41830344